Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative

Clinical trial NCT05153343 · COMPLETED

Trial details

NCT number: NCT05153343
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Neoplasm (MPN)Myelofibrosis，MF

Start date: 2021-12-27
Primary completion: 2023-11-29
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.